Serum concentrations of vascular endothelial growth factor and nitrite as an estimate of in vivo nitric oxide in patients with gastric cancer

British Journal of Cancer

Volumn 80, Issue 10, 1999, Pages 1630-1634

  Eroglu A ^a,b   Demirci, S ^a   Ayyildiz, A ^a   Kocaoglu H ^a   Akbulut, H ^a   Akgul H ^a   Elhan, H A ^a  

^a ANKARA UNIVERSITY   (Turkey)

^b Ragip Tuzun cad   (Turkey)

Author keywords

Gastric cancer; Nitric oxide; Serum; VEGF

Indexed keywords

NITRIC OXIDE; NITRITE; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; STOMACH CANCER;

EID: 0032988709     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690573     Document Type: Article

References (24)

1. Andrade SP, Hart IR and Piper PJ (1992) Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br J Pharmacol 107: 1092-1095
2. Araya M, Terashima M, Takagane A, Abe K, Nishizuka S, Yonezawa H, Irinoda T, Nakaya T and Saito K (1997) Microvessel count predicts metastasis and prognosis in patients with gastric cancer. J Surg Oncol 65: 232-236
3. Cobbs CS, Brenman JE, Aldape KD, Bredt DS and Israel MA (1995) Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 55: 727-730
4. Dong Z, Staroselsky AH, Qi X, Xie K and Fidler IJ (1994) Inverse correlation between inducible nitric oxide synthase activity and production of metastasis in K-1735 murine melanoma cells. Cancer Res 54: 789-793
5. Fidler IJ and Ellis LM (1994) The implications of angiogenesis for the biology and therapy of cancer metastasis. Cell 79: 185-188
6. Folkman J (1997) Antiangiogenic therapy. In: Cancer Principles and Practice of Oncology, DeVita VT Jr, Hellman S and Rosenberg SA (eds). pp. 3075-3085. Lippincott Raven; Philadelphia
7. Fukumura D, Yuan F, Endo M and Jain RK (1997) Role of nitric oxide in tumor microcirculation. Blood flow, vascular permeability, and leukocyte-endothelial interactions. Am J Pathol 150: 713-725
8. Gallo O, Masini E, Morbidelli L, Franchi A, Fini-Storchi I, Vergari WA and Ziehe M (1998) Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 90: 587-596
9. Hevel JM and Marletta MA (1994) Nitric oxide synthase assays. Methods Enzymol 233: 250-258
10. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC and Moncada S (1995) Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 92: 4392-4396
11. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Onoda N, Sawada T, Kato Y, Nitta A, Arimoto Y, Kondo Y and Sowa M (1995) Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 72: 319-323
12. Maeda K, Chung Y, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T and Sowa M (1996) Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77: 858-863
13. Miles DW, Happerfield LC, Thomsen LL, and Felipe I (1996) Nitric oxide synthase activity and localization in gastric carcinoma. Proc Am Assoc Cancer Res 37: 155
14. Moncada S, Palmer RM and Higgs EA (1991) Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 43: 109-142
15. Moriyama A, Masumoto A, Nanri H, Tabaru A, Unoki H, Imoto I, Ikeda M and Otsuki M (1997) High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma. Am J Gastroenterol 92: 1520-1523
16. Nathan C and Xie QW (1994) Nitric oxide synthases: roles, tolls, and controls. Cell 78: 915-918
17. Pipili-Synelos E, Sakkoula K and Maragoudakis ME (1993) Nitric oxide is involved in the regulation of angiogenesis. Br J Pharmacol 108: 855-857
18. Prival C, Lantoine F, Bedioui F, van Brussel ME, Devynck J and Devynck MA (1997) Nitric oxide production by endothelial cells: comparison of three methods of quantification. Life Sci 61: 1193-1202
19. Senger DR, Van De Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jack man RW, Dvorak AM and Dvorak HF (1993) Cancer Metastas Rev 12: 303-324
20. Sobin LH and Wittekind Ch (eds) (1997) TNM Classification of Malignant Tumours. pp 59-62 Wiley-Liss: New York
21. Thomsen LL, Lawton FG, Knowles RG, Beesley JF, Riveros-Moreno V and Moncada S (1994) Nitric oxide synthase activity in human gynecological cancer. Cancer Res 54: 1352-1354
22. Thomsen LL, Miles DW, Happerfield L, Bobrow LG, Knowles RG and Moncada S (1995) Nitric oxide synthase activity in human breast cancer. Br J Cancer 72: 41-44
23. Thomsen LL, Scott JMJ, Topley P, Knowles RG, Keerie AJ and Frend AJ (1997) Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: studies with 1400W, a novel inhibitor. Cancer Res 57: 3300-3304
24. Yamamoto Y, Toi M, Kondo S, Matsumotu T, Suzuki H, Kitamura M, Tsuruta K, Taniguchi T, Okamoto A, Mori T, Yoshida M, Ikeda T and Tominaga T (1996) Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res 2: 821-826